HF
CYCN icon

HRT Financial’s Cyclerion Therapeutics CYCN Stock Holding History

HRT Financial’s Portfolio CYCN Stock Details CYCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74K Buy
+22,054
New +$71.6K ﹤0.01% 3686
2021
Q3 		– Sell
-3,258
Closed -$254K – 3372
2021
Q2 		$254K Buy
+3,258
New +$204K ﹤0.01% 2255

Other funds holding CYCN

KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HRT Financial's CYCN Position: Q2 2026 in Review

HRT Financial opened a new position in Cyclerion Therapeutics (CYCN) in Q2 2026: 22,054 shares worth $74K. The stake represents ﹤0.01% of the portfolio and ranks #3686 among its holdings. This is a return to the name: HRT Financial previously reported a position in CYCN as recently as Q2 2021.

HRT Financial first reported a position in CYCN in Q2 2021 and has held it in 2 quarters since. The position peaked at $254K in Q2 2021. 21 funds tracked by Wall St. Rank hold CYCN as of Q2 2026.

  • HRT Financial held 22,054 shares of Cyclerion Therapeutics worth $74K as of Q2 2026.
  • Cyclerion Therapeutics was a new HRT Financial position in Q2 2026.
  • Cyclerion Therapeutics made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3686 holding.
  • HRT Financial first reported a position in Cyclerion Therapeutics in Q2 2021 and has held it in 2 quarters since.
  • HRT Financial's Cyclerion Therapeutics position peaked at $254K in Q2 2021.
  • 21 funds tracked by Wall St. Rank held Cyclerion Therapeutics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.